The net effect of deregulating the G1 cell cycle checkpoints is a highly proliferative malignancy, as evidenced by median Ki-67 positivity of >50% [171,172] relative to <5% Ki-67-positive tumor cells in malignant melanoma [173]. Here, MKI67 is linked to melanoma.